Fusobacterium nucleatum infection induces CSF3 expression through the p38 MAPK and JNK signaling pathways in oral squamous cell carcinoma cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Oral bacterial infections substantially affect the development of various periodontal diseases and oral cancers. However, the molecular mechanisms underlying the association between Fusobacterium nucleatum (F. nucleatum ), a major periodontitis (PT)-associated pathogen, and these diseases require extensive research. Previously, our RNAsequencing analysis identified a few hundred differentially expressed genes in patients with PT and peri-implantitis (PI) than in healthy controls. Thus, in the present study using oral squamous cell carcinoma (OSCC) cells, we aimed to evaluate the effect of F. nucleatum infection on genes that are differentially regulated in patients with PT and PI. Human oral squamous cell carcinoma cell lines OSC-2O, HSC-4, and HN22 were used. These cells were infected with F. nucleatum at a multiplicity of infection of 100 for 3 hours at 37 ℃ in 5% CO2 . Gene expression was then measured using reverse-transcription polymerase chain reaction. Among 18 genes tested, the expression of CSF3, an inflammation-related cytokine, was increased by F. nucleatum infection. Additionally, F. nucleatum infection increased the phosphorylation of AKT, p38 MAPK, and JNK in OSC-20 cells. Treatment with p38 MAPK (SB202190) and JNK (SP600125) inhibitors reduced the enhanced CSF3 expression induced by F. nucleatum infection. Overall, this study demonstrated that F. nucleatum promotes CSF3 expression in OSCC cells through p38 MAPK and JNK signaling pathways, suggesting that p38 MAPK and JNK inhibitors may help treat F. nucleatum -related periodontal diseases by suppressing CSF3 expression.
Abstract
Oral bacterial infections substantially affect the development of various periodontal diseases and oral cancers. However, the molecular mechanisms underlying the association between Fusobacterium nucleatum (F. nucleatum ), a major periodontitis (PT)-associated pathogen, and these diseases require extensive research. Previously, our RNAsequencing analysis identified a few hundred differentially expressed genes in patients with PT and peri-implantitis (PI) than in healthy controls. Thus, in the present study using oral squamous cell carcinoma (OSCC) cells, we aimed to evaluate the effect of F. nucleatum infection on genes that are differentially regulated in patients with PT and PI. Human oral squamous cell carcinoma cell lines OSC-2O, HSC-4, and HN22 were used. These cells were infected with F. nucleatum at a multiplicity of infection of 100 for 3 hours at 37 ℃ in 5% CO2 . Gene expression was then measured using reverse-transcription polymerase chain reaction. Among 18 genes tested, the expression of CSF3, an inflammation-related cytokine, was increased by F. nucleatum infection. Additionally, F. nucleatum infection increased the phosphorylation of AKT, p38 MAPK, and JNK in OSC-20 cells. Treatment with p38 MAPK (SB202190) and JNK (SP600125) inhibitors reduced the enhanced CSF3 expression induced by F. nucleatum infection. Overall, this study demonstrated that F. nucleatum promotes CSF3 expression in OSCC cells through p38 MAPK and JNK signaling pathways, suggesting that p38 MAPK and JNK inhibitors may help treat F. nucleatum -related periodontal diseases by suppressing CSF3 expression.
참고문헌 (48)
- Pihlstrom BL, "Periodontal diseases", Lancet, 366, pp.1809~1820 (2005)[DOI]
- Hajishengallis G, "Periodontitis : from microbial immune subversion to systemic inflammation", Nat Rev Immunol, 15, pp.30~44 (2015)[DOI]
- Lamont RJ, "The oral microbiota : dynamic communities and host interactions", Nat Rev Microbiol, 16, pp.745~759 (2018)[DOI]
- Bracci PM, "Oral health and the oral microbiome in pancreatic cancer : an overview of epidemiological studies", Cancer J, 23, pp.310~314 (2017)[DOI]
- Wang J, "Relationship between periodontal disease and lung cancer : a systematic review and meta-analysis", J Periodontal Res, 55, pp.581~593 (2020)[DOI]
- Baima G, "The gum-gut axis : periodontitis and the risk of gastrointestinal cancers", Cancers(Basel), 15, pp.4594~ (2023)[DOI]
- Kavarthapu A, "Linking chronic periodontitis and oral cancer : a review", Oral Oncol, 121, pp.105375~ (2021)[DOI]
- Cai Z, "Co-pathogens in periodontitis and inflammatory bowel disease", Front Med(Lausanne), 8, pp.723719~ (2021)[DOI]
- Mesa F, "A new comorbidity in periodontitis : Fusobacterium nucleatum and colorectal cancer", Medicina(Kaunas), 58, pp.546~ (2022)[DOI]
- Liu Y, "Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer", J Gastroenterol, 54, pp.33~41 (2019)[DOI]
- Oh JM, "The effect of oral bacterial infection on DNA damage response in host cells", Am J Cancer Res, 13, pp.3157~3168 (2023)
- Kamarajan P, "Periodontal pathogens promote cancer aggressivity via TLR", MyD88 triggered activation of Integrin, PLoS Pathog, pp.2020, 16[DOI]
- "Global Cancer Observatory: Cancer Today"[URL]
- Warnakulasuriya S, "Global epidemiology of oral and oropharyngeal cancer", Oral Oncol, 45, pp.309~316 (2009)[DOI]
- Wang B, "The recurrence and survival of oral squamous cell carcinoma : a report of 275 cases", Chin J Cancer, 32, pp.614~618 (2013)[DOI]
- Theyab A, "New insight into the mechanism of granulocyte colony-stimulating factor(G-CSF)that induces the mobilization of neutrophils", Hematology, 26, pp.628~636 (2021)[DOI]
- Wang Y, "Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy : a systematic review and Bayesian network meta-analysis", Sci Rep, 9, pp.15374~ (2019)[DOI]
- Baba M, "Establishment and characteristics of a gastric cancer cell line(HuGC-OOHIRA)producing high levels of GCSF, GM-CSF, and IL-6 : the presence of autocrine growth control by G-CSF", Am J Hematol, 49, pp.207~215 (1995)[DOI]
- Bahar B, "Granulocyte colony stimulating factor(G-CSF)and macrophage colony stimulating factor(M-CSF)as potential tumor markers in non small cell lung cancer diagnosis", Asian Pac J Cancer Prev, 11, pp.709~712 (2010)
- Matsuda A, "Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor : report of a case", Surg Today, 39, pp.990~993 (2009)[DOI]
- Wang J, "Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells", Cancer Biol Ther, 13, pp.389~400 (2012)[DOI]
- Kumar J, "Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2", signal transducer and activator of transcription 3 in ovarian cancer, 2014, pp.110, 133~145
- Oh JM, "Comparative transcriptome analysis of periodontitis and peri-implantitis in human subjects", J Periodontol (2023)[DOI]
- Kang W, "Fusobacterium nucleatum facilitates apoptosis, ROS generation, and inflammatory cytokine production by activating AKT", MAPK and NF-κB signaling pathways in human gingival fibroblasts, 2019, pp.2019, 1681972~
- Park SR, "Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages", Infect Immun, 82, pp.1914~1920 (2014)[DOI]
- Suzuki R, "Periodontopathic bacterium Fusobacterium nucleatum affects matrix metalloproteinase-9 expression in human alveolar epithelial cells and mouse lung", In Vivo, 36, pp.649~656 (2022)[DOI]
- Saunders AS, "Colonystimulating factor 3 signaling in colon and rectal cancers : immune response and CMS classification in TCGA data", PLoS One, 16, pp.e0247233~ (2021)[DOI]
- Morris KT, "G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration", Br J Cancer, 110, pp.1211~1220 (2014)[DOI]
- Karagiannidis I, "GCSF in tumors : aggressiveness, tumor microenvironment and immune cell regulation", Cytokine, 142, pp.155479~ (2021)[DOI]
- Hayashi E, "Simultaneous production of G-and M-CSF by an oral cancer cell line and the synergistic effects on associated leucocytosis", Eur J Cancer B Oral Oncol, 31B, pp.323~327 (1995)[DOI]
- Fresno Vara JA, "PI3K", Akt signalling pathway and cancer, 2004, pp.30, 193~204
- Bubici C, "JNK signalling in cancer : in need of new, smarter therapeutic targets", Br J Pharmacol, 171, pp.24~37 (2014)[DOI]
- Bradham C, "p38 MAPK in development and cancer", Cell Cycle, 5, pp.824~828 (2006)[DOI]
- Cuenda A, "p38 MAP-kinases pathway regulation, function and role in human diseases", Biochim Biophys Acta, 1773, pp.1358~1375 (2007)[DOI]
- Schieven GL, "The biology of p38 kinase : a central role in inflammation", Curr Top Med Chem, 5, pp.921~928 (2005)[DOI]
- Hammouda MB, "The JNK signaling pathway in inflammatory skin disorders and cancer", Cells, 9, pp.857~ (2020)[DOI]
- Wu Q, "Selective inhibitors for JNK signalling : a potential targeted therapy in cancer", J Enzyme Inhib Med Chem, 35, pp.574~583 (2020)[DOI]
- Yong HY, "The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer", Expert Opin Investig Drugs, 18, pp.1893~1905 (2009)[DOI]
- Choi JI, "Vaccines against periodontitis : a forward-looking review", J Periodontal Implant Sci, 40, pp.153~163 (2010)[DOI]
- Kuramitsu HK, "Interspecies interactions within oral microbial communities", Microbiol Mol Biol Rev, 71, pp.653~670 (2007)[DOI]
- Yin L, "Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human betadefensin-2", J Med Microbiol, 56(Pt 7), pp.976~987 (2007)[DOI]
- Geng F, "Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70", p53 pathway in oral cancer cells, 2020, pp.39, 144~151
- Zhang S, "Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG", miR-296-5p, SNAI1 signaling pathway, pp.FEBS J, 2020[DOI]
- Udayasuryan B, "Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling", Sci Signal, 15, pp.eabn4948~ (2022)[DOI]
- Michaud DS, "Role of bacterial infections in pancreatic cancer", Carcinogenesis, 34, pp.2193~2197 (2013)[DOI]
- Gholizadeh P, "Role of oral microbiome on oral cancers, a review", Biomed Pharmacother, 84, pp.552~558 (2016)[DOI]
- Ha NH, "Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs", Cytokine, 86, pp.64~72 (2016)[DOI]
- Ha NH, "Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties", Tumour Biol, 36, pp.9947~9960 (2015)[DOI]